secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001104659-25-060706
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences raises ~$6.3M to boost equity above Nasdaq $2.5M minimum
-----------------------------------------------------------------------------

- Raised $3.64M (593K shares) via ATM June 3-6, and $2.64M (1.05M shares) in direct offering June 9.
- Proceeds brought stockholders' equity from $1.2M to above the $2.5M Nasdaq minimum.
- Despite cure, delisting risk remains; Nasdaq hearing requested to stay suspension.
- Company previously disclosed non-compliance with Nasdaq Listing Rule 5550(b)(1) on May 28, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925060706/0001104659-25-060706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925060706/tm2518350d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-060706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer